JOURNAL ARTICLE

A narrative review of the neuropharmacology of synthetic cathinones—Popular alternatives to classical drugs of abuse.

  • Published In: Human Psychopharmacology: Clinical & Experimental, 2023, v. 38, n. 3. P. 1 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Kuropka, Patryk; Zawadzki, Marcin; Szpot, Paweł 3 of 3

Abstract

Objective: To review the literature on the neuropharmacology of synthetic cathinones. Methods: A comprehensive literature search was carried out across multiple databases (mainly PubMed, World Wide Web, and Google Scholar) using relevant keywords. Results: Cathinones exhibit a broad toxicological profile, mimicking the effects of a wide variety of 'classic drugs' such as 3,4‐methylenedioxymethamphetamine (MDMA), methamphetamine and cocaine. Even small structural changes affect their interactions with key proteins. This article reviews existing knowledge of the mechanisms of action of cathinones at the molecular level, and key findings from research on their structure‐activity relationship. The cathinones are also classified according to their chemical structure and neuropharmacological profiles. Conclusions: Synthetic cathinones represent one of the most numerous and widespread groups among new psychoactive substances. Initially developed for therapeutic purposes, they quickly started to be used recreationally. With a rapidly increasing number of new agents entering the market, structure‐activity relationship studies are valuable for assessing and predicting the addictive potential and toxicity of new and potential future substances. The neuropharmacological properties of synthetic cathinones are still not fully understood. A full elucidation of the role of some key proteins, including organic cation transporters, requires detailed studies. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Human Psychopharmacology: Clinical & Experimental. 2023/05, Vol. 38, Issue 3, p1
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2023
  • ISSN:0885-6222
  • DOI:10.1002/hup.2866
  • Accession Number:163567745
  • Copyright Statement:Copyright of Human Psychopharmacology: Clinical & Experimental is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.